A Novel Cell-based Luciferase Reporter Platform for the Development and Characterization of T-Cell Redirecting Therapies and Vaccine Development.
一种用于开发和表征 T 细胞重定向疗法和疫苗开发的新型基于细胞的荧光素酶报告平台
期刊:Journal of Immunotherapy
影响因子:2.9
doi:10.1097/CJI.0000000000000453
Grailer Jamison, Cheng Zhijie Jey, Hartnett Jim, Slater Michael, Fan Frank, Cong Mei
